Effective Use of Alteplase for Occluded Tunneled Venous Catheter in Hemodialysis Patients
- 3 October 2013
- journal article
- research article
- Published by Wiley in Artificial Organs
- Vol. 38 (5) , 399-403
Abstract
Despite their propensity for significant infectious and mechanical complications, tunneled central venous catheters (CVCs) have become a common means of vascular access in the world for patients requiring chronic hemodialysis for end‐stage renal disease. The objective of this study was to explore if cryopreserved solutions of the thrombolytic agent alteplase could be used as an effective, safe, and economically reasonable alternative in hemodialysis patients with occluded tunneled CVC. Patients requiring chronic hemodialysis and presenting with occluded tunneled CVC received a sufficient volume of the alteplase solution to fill the occluded catheter. To make alteplase economically feasible, it was diluted to 1‐mg/mL aliquots and they were stored at −20°C until use. Eighty‐one patients accounting for 179 attempted clearances were assessable for efficacy. One hundred forty‐seven (82.1%) of the 179 catheter clearance attempts resulted in successful catheter clearance after one dose. Twenty‐seven (15.1%) of all occluded CVCs were successful after two doses whereas five (2.8%) were not. No adverse events were reported. Cryopreserved 1‐mg/mL aliquots of alteplase are safe and effective in the clearance of occluded CVC for hemodialysis patients.Keywords
This publication has 17 references indexed in Scilit:
- Tunneled Dialysis Catheters: Recent Trends and Future DirectionsAdvances in Chronic Kidney Disease, 2009
- UNRESOLVED ISSUES IN DIALYSIS: Long‐Term Management of the Tunneled Venous CatheterSeminars in Dialysis, 2006
- Tunneled Catheters in Hemodialysis Patients: Reasons and Subsequent OutcomesAmerican Journal of Kidney Diseases, 2005
- Special Article: National Surveillance of Dialysis‐Associated Diseases in the United States, 2001Seminars in Dialysis, 2004
- Safe and Cost Effective Use of Alteplase for the Clearance of Occluded Central Venous Access DevicesJournal of Clinical Oncology, 2002
- Catheter ThrombosisSeminars in Dialysis, 2001
- Recombinant Tissue Plasminogen Activator (Alteplase) for Restoration of Flow in Occluded Central Venous Access Devices: A Double-Blind Placebo-Controlled Trial—The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy TrialJournal of Vascular and Interventional Radiology, 2001
- Activity and dosage of alteplase dilution for clearing occlusions of venous-access devicesAmerican Journal of Health-System Pharmacy, 2000
- Silastic cuffed catheters for hemodialysis vascular access: Thrombolytic and mechanical correction of malfunctionAmerican Journal of Kidney Diseases, 1996
- Fibrin sleeve stripping for salvage of failing hemodialysis catheters: technique and initial results.Radiology, 1996